Barco gets FDA OK for mammography CRT

Barco this week announced Food and Drug Administration 510K clearance for its CRT-based MGD 521M display.

The 5 mega pixel MGD 521M Medical Grayscale Display has been available on the market for a couple years, but recent FDA approval allows the unit to be sold as a dedicated mammography display.

The display is equipped with a high luminance of 450 cd/m² and contrast ratio of 2000:1. It incorporates a luminance uniformity correction function as well as a digital focus and astigmatism correction for sharpness needed to interpret digital mammography cases.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.